101 related articles for article (PubMed ID: 1904050)
1. Induction of in vitro and in vivo anti-tumor responses by sensitization of mice with liposomes containing a crude butanol extract of leukemia cells and transferred inter-membranously with cell-surface proteins.
Shibata R; Noguchi T; Sato T; Akiyoshi K; Sunamoto J; Shiku H; Nakayama E
Int J Cancer; 1991 May; 48(3):434-42. PubMed ID: 1904050
[TBL] [Abstract][Full Text] [Related]
2. Cell surface antigens of radiation leukemia virus-induced BALB/c leukemias defined by syngeneic cytotoxic T lymphocytes.
Kaneko Y; Oettgen HF; Obata Y; Nakayama E
Jpn J Cancer Res; 1989 Mar; 80(3):257-64. PubMed ID: 2542207
[TBL] [Abstract][Full Text] [Related]
3. Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.
Morishita H; Shiku H; Horibe K; Obata Y; Stockert E; Oettgen HF; Old LJ; Yamada K
J Exp Med; 1986 Feb; 163(2):452-7. PubMed ID: 3003228
[TBL] [Abstract][Full Text] [Related]
4. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
Matsuo M; Wada H; Honda S; Tawara I; Uenaka A; Kanematsu T; Nakayama E
J Immunol; 1999 Jun; 162(11):6420-5. PubMed ID: 10352255
[TBL] [Abstract][Full Text] [Related]
5. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
Henderson LA; Ciavarra R; Riblet R; Forman J
J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
[TBL] [Abstract][Full Text] [Related]
6. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
[TBL] [Abstract][Full Text] [Related]
7. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
8. Differential extraction of tumor-specific transplantation antigen and embryonic antigen from simian virus 40- and adenovirus 7-induced sarcoma cells of hamsters with 1-butanol and 3 M potassium chloride.
Coggin JH; Gillis LD; Payne WJ
J Natl Cancer Inst; 1984 Apr; 72(4):853-62. PubMed ID: 6323810
[TBL] [Abstract][Full Text] [Related]
9. Maturation of cytolytic T lymphocytes.
Moscovitch M; Grossman Z; Rosen D; Berke G
Cell Immunol; 1986 Oct; 102(1):52-67. PubMed ID: 3492278
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia.
Manki A; Ono T; Uenaka A; Seino Y; Nakayama E
Cancer Res; 1998 May; 58(9):1960-4. PubMed ID: 9581839
[TBL] [Abstract][Full Text] [Related]
11. Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection.
Nakayama E; Uenaka A
J Exp Med; 1985 Feb; 161(2):345-55. PubMed ID: 3871834
[TBL] [Abstract][Full Text] [Related]
12. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb.
Ito D; Ogasawara K; Iwabuchi K; Inuyama Y; Onoé K
J Immunol; 2000 Feb; 164(3):1230-5. PubMed ID: 10640735
[TBL] [Abstract][Full Text] [Related]
13. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
Nagarkatti M; Kaplan AM
J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
[TBL] [Abstract][Full Text] [Related]
14. [Characterization of autologous-tumor specific cytotoxic T cells induced by means of butanol-extracted soluble antigen from T lymphocytes in colon cancer patients].
Hamagashira K
Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):128-37. PubMed ID: 8464410
[TBL] [Abstract][Full Text] [Related]
15. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
16. Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
Greenberg PD; Kern DE; Cheever MA
J Exp Med; 1985 May; 161(5):1122-34. PubMed ID: 3921652
[TBL] [Abstract][Full Text] [Related]
17. Analysis of protective and cytotoxic immune responses in vivo against metabolically inactivated and untreated cells of a mutagenized tumor line (requirements for tumor immunogenicity).
Wehrmaker A; Lehmann V; Dröge W
Cell Immunol; 1986 Sep; 101(2):290-8. PubMed ID: 2428514
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of in vivo generation of cytotoxic activity against syngeneic tumours. I. Local differentiation of mature cytotoxic T lymphocytes in the rejection of tumours.
Tsuru S; Aiso S; Taniguchi M; Zinnaka Y; Nomoto K
Immunology; 1985 Feb; 54(2):281-8. PubMed ID: 3871419
[TBL] [Abstract][Full Text] [Related]
19. Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies.
Rosenstein M; Rosenberg SA
J Natl Cancer Inst; 1984 May; 72(5):1161-5. PubMed ID: 6609266
[TBL] [Abstract][Full Text] [Related]
20. Cellular immune reactivity in vitro and tumor rejection provided by tumor-associated antigens of friend-virus-induced leukemia.
Dean JH; McCoy JL; Law LW; Maurer BA; Appella E
Int J Cancer; 1975 Nov; 16(5):701-12. PubMed ID: 1184239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
